(H&J News) On Sunday, April 14, 2019, Ms. Wang, an expert on drug safety and Pharmacovigilance in Hua Medicine, was invited to visit our company and share with the knowledge and practical experience of PV.

PV is a scientific research and activity that discovers, evaluates, understands and prevents adverse reactions or any other possible drug-related problems. It runs through the whole life cycle of drugs. Drug supervision departments in China and abroad have stricter requirements on PV and more detailed regulations and management.

Ms. Wang's lecture not only talked about the requirements of GVP, E2A~F and CFDA in terms of laws and regulations, but also talked about the core activities and contents of PV from the practical level. It also talked about SOP items before, after and during the whole process of drug development. She also talked about what contents could be outsourced or could not be outsourced.